Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Urology

• Publication date

  2008-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.juro.2008.01.047PMID 18353383PMCID PMC2705752
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Uroplakin III-delta4 messenger RNA as a promising marker to identify nonulcerative interstitial cystitis.

  2007cited by this paper
• Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion.

  2006cited by this paper
• Efficacy of prednisone for severe refractory ulcerative interstitial cystitis.

  2005cited by this paper
• Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis?

  2005cited by this paper
• Regulation of tight junction proteins and bladder epithelial paracellular permeability by an antiproliferative factor from patients with interstitial cystitis.

  2005cited by this paper
• APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis

  2005cited by this paper
• Nitric oxide as an objective marker for evaluation of treatment response in patients with classic interstitial cystitis.

  2004cited by this paper
• Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis.

  2004cited by this paper
• Changes in human bladder epithelial cell gene expression associated with interstitial cystitis or antiproliferative factor treatment.

  2003cited by this paper
• Toward a precise definition of interstitial cystitis: further evidence of differences in classic and nonulcer disease.

  2002cited by this paper
• Mast cell activation triggers a urothelial inflammatory response mediated by tumor necrosis factor-alpha.

  2002cited by this paper
• A comparison of multiple urine markers for interstitial cystitis.

  2002cited by this paper
• Mast Cell Activation Triggers a Urothelial Inflammatory Response Mediated by Tumor Necrosis Factor-α

  2002cited by this paper
• Use of the neodymium: YAG laser for interstitial cystitis: a prospective study.

  2001cited by this paper
• Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study.

  2001cited by this paper
• Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production.

  2000cited by this paper
• The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study.

  1999cited by this paper
• Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis.

  1998cited by this paper
• ORIGIN OF URINARY EPIDERMAL GROWTH FACTOR IN HUMANS: EXCRETION OF ENDOGENOUS EGF AND INFUSED [131I]‐HUMAN EGF AND KIDNEY HISTOCHEMISTRY

  1992cited by this paper
• Histamine and mucosal mast cells in interstitial cystitis

  1989cited by this paper
• Salmon calcitonin and cGMP production by human kidney: Studies in vivo and in vitro

  1983cited by this paper

• The Role of Biomarkers in the Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome: What Does Current Evidence Reveal?

  2025cites this paper
• How Can We Make Progress in the Management of Bladder Pain Syndrome? ICI-RS 2025.

  2025cites this paper
• Cytokines in Bladder Pain Syndrome: A Review of the Literature

  2024cites this paper
• Can montelukast sodium be an alternative treatment in the treatment of interstitial cystitis?

  2023cites this paper
• Unraveling the complexity of bladder-centric chronic pain by intravesical contrast enhanced MRI

  2023cites this paper
• Chronic Pelvic Pain, Vulvar Pain Disorders, and Proteomics Profiles: New Discoveries, New Hopes

  2023cites this paper
• Can We Use Urinary Cytokine/Chemokine Analysis in Discriminating Ulcer-Type Interstitial Cystitis/Bladder Pain Syndrome?

  2022cites this paper
• Prevalence, Risk Factors, Pathophysiology, Potential Biomarkers and Management of Feline Idiopathic Cystitis: An Update Review

  2022cites this paper
• Comparison of deep phenotyping features of UCPPS with and without Hunner lesion: A MAPP‐II Research Network Study

  2021cites this paper
• Exploration of the core genes in ulcerative interstitial cystitis/bladder pain syndrome

  2021cites this paper
• Comparison of Intravesical Hyaluronic Acid, Chondroitin Sulfate, and Combination of Hyaluronic Acid-Chondroitin Sulfate Therapies in Animal Model of Interstitial Cystitis

  2021cites this paper
• Feline Idiopathic Cystitis: Pathogenesis, Histopathology and Comparative Potential.

  2021cites this paper
• Virtual Measurements of Paracellular Permeability and Chronic Inflammation Via Color Coded Pixel-wise T1 Mapping.

  2020cites this paper
• Hunner lesion disease differs in diagnosis, treatment and outcome from bladder pain syndrome: an ESSIC working group report

  2020cites this paper
• Hunner Lesion Phenotype in Interstitial Cystitis/Bladder Pain Syndrome: A Systematic Review and Meta-Analysis.

  2020cites this paper
• Role of urinary cations in the etiology of interstitial cystitis: A multisite study

  2020cites this paper
• Bladder Pain Syndrome/Interstitial Cystitis

  2020influential citation
• Hunner lesion versus non‐Hunner lesion interstitial cystitis/bladder pain syndrome

  2019cites this paper
• Feline Interstitial Cystitis Enhances Mucosa-Dependent Contractile Responses to Serotonin

  2018cites this paper
• Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder

  2018cites this paper
• Analysis of key genes and micro-RNA-mRNA regulatory networks in women with ulcerative interstitial cystitis/pain bladder syndrome

  2018cites this paper
• Recent advances in imaging and understanding interstitial cystitis

  2018cites this paper
• Innovative Intravesical Therapies

  2017cites this paper
• Childhood trauma perpetrated by close others, psychiatric dysfunction, and urological symptoms in patients with interstitial cystitis/bladder pain syndrome.

  2017cites this paper
• Immunomodulators for Interstitial Cystitis/Bladder Pain Syndrome

  2017cites this paper
• Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome

  2017cites this paper
• Bladder Pain Syndromes/Interstitial Cystitis and the Overactive Pelvic Floor

  2016cites this paper
• Biomarkers for interstitial cystitis/painful bladder syndrome "Urinary elevation of proteins associated with interstitial cystitis/painful bladder syndrome may be due to lesser dilution of proteins shed into urine or due to lower levels of proteases in urine compared to plasma."

  2016cites this paper
• Biomarkers for Interstitial Cystitis/Painful Bladder Syndrome

  2016cites this paper
• Increased toxic urinary cations in males with interstitial cystitis: a possible cause of bladder symptoms

  2016cites this paper
• Implications for bidirectional signaling between afferent nerves and urothelial cells—ICI‐RS 2014

  2016cites this paper
• Hyaluronic acid decreases IL-6 and IL-8 secretion and permeability in an inflammatory model of interstitial cystitis.

  2015cites this paper
• Current and emerging drugs for interstitial cystitis/bladder pain syndrome (IC/BPS)

  2015cites this paper
• Cyclophosphamide and ifosfamide: mechanisms of cytotoxic action and consequences for normal bladder function.

  2015influential citation
• The Challenges of Interstitial Cystitis: Current Status and Future Prospects

  2015cites this paper
• Classic Interstitial Cystitis: Unrelated to BPS

  2015cites this paper
• What is the role for biomarkers for lower urinary tract disorders? ICI‐RS 2013

  2014cites this paper
• Urinary bladder, cystitis and nerve/urothelial interactions.

  2014cites this paper
• Long-term ketamine abuse induces cystitis in rats by impairing the bladder epithelial barrier

  2014cites this paper
• NGF and HB-EGF: Potential Biomarkers that Reflect the Effects of Fesoterodine in Patients with Overactive Bladder Syndrome

  2014cites this paper
• Increased Severity of Inflammation Correlates with Elevated Expression of TRPV1 Nerve Fibers and Nerve Growth Factor on Interstitial Cystitis/Bladder Pain Syndrome

  2014cites this paper
• Role of urinary cations in the aetiology of bladder symptoms and interstitial cystitis

  2014cites this paper
• Cytokine expression in patients with bladder pain syndrome/interstitial cystitis ESSIC type 3C.

  2014cites this paper
• Inflammation and Chronic Pelvic Pain: A Biological Trigger for Depression

  2013cites this paper
• Urine Biomarkers and Bladder Pain Syndrome

  2013cites this paper
• Award Number: W81XWH-12-1-0565 TITLE: Intravesical NGF Antisense Therapy Using Lipid Nanoparticle For Interstitial Cystitis

  2013cites this paper
• Nitric oxide as a marker for evaluation of treatment effect of cyclosporine A in patients with bladder pain syndrome/interstitial cystitis type 3C

  2013cites this paper
• Increased Pro-Inflammatory Cytokines, C-Reactive Protein and Nerve Growth Factor Expressions in Serum of Patients with Interstitial Cystitis/Bladder Pain Syndrome

  2013cites this paper
• Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C

  2013cites this paper
• Methods and incentives for the early diagnosis of bladder pain syndrome/interstitial cystitis.

  2013cites this paper
• Urothelial signaling.

  2013cites this paper
• Autoinflammatory disorders, pain, and neural regulation of inflammation.

  2013cites this paper
• Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis/bladder pain syndrome.

  2012cites this paper
• Gene expression analysis of urine sediment: evaluation for potential noninvasive markers of interstitial cystitis/bladder pain syndrome.

  2012cites this paper
• Bladder pain syndrome/interstitial cystitis. Studies on classic BPS/IC, ESSIC type 3C, with special reference to the role of nitric oxide

  2012cites this paper
• Protein expression profiling in interstitial cystitis/painful bladder syndrome: A pilot study of proteins associated with inflammation, apoptosis, and angiogenesis

  2012cites this paper
• Basic and Translational Science Differences in Mast Cell Infiltration, E-cadherin, and Zonula Occludens-1 Expression Between Patients With Overactive Bladder and Interstitial Cystitis/Bladder Pain Syndrome

  2012cites this paper
• GLT-1 over-expression attenuates visceral nociception by pharmacological and gene therapy approaches

  2012cites this paper
• Coining a new term-Urovesicology: advancing towards a mechanistic understanding of bladder symptoms

  2012cites this paper
• Bladder Pain Syndrome (Interstitial Cystitis) and Related Disorders

  2012cites this paper
• Cyclosporine A for refractory interstitial cystitis/bladder pain syndrome: experience of 3 tertiary centers.

  2012cites this paper
• Idiopathic Cyst i t is in Domestic Cats—Beyond the Lower Urinary Tract

  2011cites this paper
• Cystitis, Co‐morbid disorders and associated epithelial dysfunction

  2011cites this paper
• Idiopathic cystitis in domestic cats--beyond the lower urinary tract.

  2011cites this paper
• Models of inflammation of the lower urinary tract

  2011influential citation
• Idiopathic C ystitis i n D ome stic C ats—Beyond t he L ower Urinary T ract

  2011cites this paper
• CXCR3 binding chemokine and TNFSF14 over expression in bladder urothelium of patients with ulcerative interstitial cystitis.

  2010cites this paper
• Bladder pain syndrome international consultation on incontinence

  2010cites this paper
• Urinary proteomics evaluation in interstitial cystitis/painful bladder syndrome: a pilot study.

  2010cites this paper
• Painful Bladder Syndrome

  2010cites this paper
• Painful bladder syndrome: Is consensus possible?

  2009cites this paper
• Interstitial cystitis: an unsolved enigma.

  2009cites this paper
• Interleukin-8 is essential for normal urothelial cell survival.

  2009cites this paper
• Differentiating interstitial cystitis from similar conditions commonly seen in gynecologic practice.

  2009cites this paper
• Painful bladder syndrome: Is consensus possible?

  2009cites this paper
• Bladder Pain Syndrome International Consultation on Incontinence Chairman

  2009cites this paper
• Gene expression profile of bladder tissue of patients with ulcerative interstitial cystitis

  2009influential citation
• Decreased nanobacteria levels and symptoms of nanobacteria-associated interstitial cystitis/painful bladder syndrome after tetracycline treatment

  2009influential citation
• Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome

  2009cites this paper
• What’s new in the diagnosis and management of painful bladder syndrome/interstitial cystitis?

  2008cites this paper
• Interstitial cystitis: bladder pain and beyond

  2008cites this paper